T1	outcome 1328 1336	toxicity
T2	outcome 1256 1279	TTF or overall response
T3	outcome 1154 1169	hazard of death
T6	outcome 899 905	deaths
T7	cv-bin-abs 907 910	166
T8	iv-bin-abs 933 936	613
T9	outcome 946 955	median OS
T10	cv-cont-median 960 971	14.3 months
T11	iv-cont-median 998 1010	18.75 months
T16	intervention 478 483	white
T17	control-participants 494 497	195
T18	intervention-participants 474 477	787
T19	control 498 514	African American
T20	eligibility 521 559	patients with metastatic breast cancer
T4	intervention 0 18	Racial differences
T5	outcome 1426 1441	hazard of death
